These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15557529

  • 1. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.
    Gordon MF, Brashear A, Elovic E, Kassicieh D, Marciniak C, Liu J, Turkel C, BOTOX Poststroke Spasticity Study Group.
    Neurology; 2004 Nov 23; 63(10):1971-3. PubMed ID: 15557529
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.
    J Rehabil Med; 2011 May 23; 43(6):486-92. PubMed ID: 21533328
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C.
    Stroke; 2000 Oct 23; 31(10):2402-6. PubMed ID: 11022071
    [Abstract] [Full Text] [Related]

  • 4. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM.
    J Neurol Neurosurg Psychiatry; 2000 Aug 23; 69(2):217-21. PubMed ID: 10896696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.
    Eur J Neurol; 2001 Nov 23; 8(6):559-65. PubMed ID: 11784339
    [Abstract] [Full Text] [Related]

  • 8. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):395-400. PubMed ID: 12167681
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct 08; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R.
    Eur J Phys Rehabil Med; 2013 Aug 08; 49(4):483-9. PubMed ID: 23480980
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A, McAfee AL, Kuhn ER, Fyffe J.
    Arch Phys Med Rehabil; 2004 May 08; 85(5):705-9. PubMed ID: 15129392
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, Takahashi K.
    Toxins (Basel); 2020 Feb 18; 12(2):. PubMed ID: 32085529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IncobotulinumtoxinA Treatment in Upper-Limb Poststroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life.
    Marciniak C, Munin MC, Brashear A, Rubin BS, Patel AT, Slawek J, Hanschmann A, Hiersemenzel R, Elovic EP.
    PM R; 2020 May 18; 12(5):491-499. PubMed ID: 31647185
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P, Slawek J, Denes Z, Platz T, Sassin I, Comes G, Grafe S.
    Clin Neuropharmacol; 2009 May 18; 32(5):259-65. PubMed ID: 19644361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.